PREGNANCY MULTIVITAMIN FOLIC 5 TABLET

Country: Canada

Language: English

Source: Health Canada

Active ingredient:

BETA-CAROTENE; FOLIC ACID; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE); IRON (FERROUS FUMARATE); VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); ASCORBIC ACID; COPPER (COPPER GLUCONATE); IODINE (POTASSIUM IODIDE); MAGNESIUM (MAGNESIUM OXIDE); ZINC (ZINC OXIDE); VITAMIN B12 (CYANOCOBALAMIN); VITAMIN D3 (CHOLECALCIFEROL); CALCIUM (CALCIUM CARBONATE); VITAMIN B1 (THIAMINE MONONITRATE); VITAMIN B2 (RIBOFLAVIN); NICOTINAMIDE; D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)

Available from:

JAMP PHARMA CORPORATION

ATC code:

B03AE04

INN (International Name):

IRON, MULTIVITAMINS AND MINERALS

Dosage:

1.6MG; 5MG; 13.8MG; 35MG; 10MG; 120MG; 2MG; 0.15MG; 50MG; 15MG; 12MCG; 600UNIT; 300MG; 3MG; 3.4MG; 20MG; 5MG

Pharmaceutical form:

TABLET

Composition:

BETA-CAROTENE 1.6MG; FOLIC ACID 5MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8MG; IRON (FERROUS FUMARATE) 35MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10MG; ASCORBIC ACID 120MG; COPPER (COPPER GLUCONATE) 2MG; IODINE (POTASSIUM IODIDE) 0.15MG; MAGNESIUM (MAGNESIUM OXIDE) 50MG; ZINC (ZINC OXIDE) 15MG; VITAMIN B12 (CYANOCOBALAMIN) 12MCG; VITAMIN D3 (CHOLECALCIFEROL) 600UNIT; CALCIUM (CALCIUM CARBONATE) 300MG; VITAMIN B1 (THIAMINE MONONITRATE) 3MG; VITAMIN B2 (RIBOFLAVIN) 3.4MG; NICOTINAMIDE 20MG; D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5MG

Administration route:

ORAL

Units in package:

15G/50G

Prescription type:

Prescription

Product summary:

Active ingredient group (AIG) number: 1747661006; AHFS:

Authorization status:

APPROVED

Authorization date:

2023-04-25

Summary of Product characteristics

_Pregnancy Multivitamin Folic 5 Product Monograph_
Page 1 of 32
PRODUCT MONOGRAPH
PR
PREGNANCY MULTIVITAMIN FOLIC 5
Vitamin-Mineral Supplement Tablets High Dose Folic Acid for Prenatal
Use
Multivitamins and other Minerals Including Combinations
JAMP Pharma Corporation
1310 rue Nobel
Boucherville, Quebec
J4B 5H3, Canada
Control No.:252151
Date of Preparation:
April 25, 2023
_Pregnancy Multivitamin Folic 5 Product Monograph_
Page 2 of 32
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
...............................................................................................................
3
INDICATIONS AND CLINICAL USE
....................................................................................................................
4
CONTRAINDICATIONS
.........................................................................................................................................
4
WARNINGS AND PRECAUTIONS
........................................................................................................................
5
ADVERSE REACTIONS
..........................................................................................................................................
7
DRUG INTERACTIONS
........................................................................................................................................
10
DOSAGE AND ADMINISTRATION
....................................................................................................................
15
OVERDOSAGE
......................................................................................................................................................
17
ACTION AND CLINICAL PHARMACOLOGY
...................................................................................................
17
STORAGE AND STABILITY
............................................................................................................